Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxium in Diabetic Retinopathy
NCT01382498Phase 4Unknown
- Sponsor
- University of Tabriz
- Start
- Nov 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcium dobesilate in diabetic retinopathy (DR), sponsored by University of Tabriz. Status: unknown.
02
Drugs
calcium dobesilate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT01382498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382498.